$327 Million Viral Clearance Global Market – Featuring Clean Cells, Lonza Group and SGS Among Others – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Viral Clearance – Global Market Trajectory & Analytics” report has been added to ResearchAndMarkets.com’s offering.

Amid the COVID-19 crisis, the global market for Viral Clearance estimated at US$327 Million in the year 2020, is projected to reach a revised size of US$1.1 Billion by 2027, growing at a CAGR of 18.5% over the analysis period 2020-2027.

Recombinant Proteins, one of the segments analyzed in the report, is projected to record a 18.9% CAGR and reach US$250.3 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Blood and Blood Products segment is readjusted to a revised 16.3% CAGR for the next 7-year period.

The U.S. Market is Estimated at $97.4 Million, While China is Forecast to Grow at 18.2% CAGR

The Viral Clearance market in the U.S. is estimated at US$97.4 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$188.9 Million by the year 2027 trailing a CAGR of 18.2% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 16.4% and 15.6% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 12.9% CAGR.

Vaccines Segment to Record 18.5% CAGR

In the global Vaccines segment, USA, Canada, Japan, China and Europe will drive the 18.4% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$92.6 Million in the year 2020 will reach a projected size of US$302.7 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$124.6 Million by the year 2027.

Select Competitors (Total 41 Featured):

• Avance Biosciences Inc.
• BSL BIOSERVICE Scientific Laboratories Munich GmbH
• Charles River Laboratories International, Inc.
• Clean Cells Inc.
• Lonza Group AG
• Merck KgaA
• SGS SA
• Sigma-Aldrich Corporation
• Texcell, Inc.

Key Topics Covered:

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

• Influencer Market Insights
• World Market Trajectories
• Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS

IV. COMPETITION

• Total Companies Profiled: 41

For more information about this report visit https://www.researchandmarkets.com/r/fp48ag

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]
For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900